Association between Age-Related Macular Degeneration and Mortality in a High Cardiovascular Risk Cohort: A

Richard Kha1, George Burlutsky1, Aravinda Thiagalingam2

  • 1Centre for Vision Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.

Ophthalmology. Retina
|March 2, 2025
PubMed

Insights

Age-related macular degeneration (AMD) independently predicts higher all-cause mortality in individuals at high risk for cardiovascular disease (CVD). Early AMD also increases the risk of CVD mortality, suggesting shared underlying pathways.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Public Health

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Cardiovascular disease (CVD) remains a major global health concern.
  • The potential link between AMD and CVD mortality risk is not fully understood.

Purpose of the Study:

  • To determine if AMD predicts all-cause and CVD mortality in a high-risk cohort.
  • To investigate the association between different stages of AMD and mortality outcomes.

Main Methods:

  • Prospective cohort study of 1545 adults evaluated for acute coronary syndrome.
  • AMD assessed from fundus photographs; coronary artery disease severity graded by Gensini score.
  • Mortality data collected over 9 years via linkage with the Australian National Death Index; Cox regression used.

Main Results:

  • Any AMD (6.9%) was present in 107 participants; 15.1% died over 9 years, with 11.3% from CVD.
  • After adjusting for confounders, any AMD, early AMD, and late AMD predicted increased all-cause mortality.
  • Any AMD and early AMD were associated with increased CVD mortality; late AMD was not.

Conclusions:

  • AMD at any stage independently predicts higher all-cause mortality in high-CVD-risk individuals.
  • Early AMD is also linked to increased CVD mortality, suggesting shared pathophysiological mechanisms.
  • Further research is needed to elucidate the shared pathways between AMD and CVD.
Abstract